Arcturus Therapeutics Holdings Inc (ARCT)
18.30
+0.48
(+2.69%)
USD |
NASDAQ |
Nov 05, 16:00
18.30
0.00 (0.00%)
After-Hours: 18:51
Arcturus Therapeutics Holdings Cash from Financing (Quarterly): 2.403M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.403M |
| March 31, 2024 | 2.188M |
| December 31, 2023 | -18.66M |
| September 30, 2023 | 21.84M |
| June 30, 2023 | 0.094M |
| March 31, 2023 | -27.36M |
| December 31, 2022 | -2.232M |
| September 30, 2022 | -1.22M |
| June 30, 2022 | 0.257M |
| March 31, 2022 | 0.336M |
| December 31, 2021 | 0.23M |
| September 30, 2021 | 0.692M |
| June 30, 2021 | 0.082M |
| March 31, 2021 | 47.01M |
| December 31, 2020 | 163.20M |
| September 30, 2020 | 187.22M |
| June 30, 2020 | 85.60M |
| March 31, 2020 | 0.118M |
| December 31, 2019 | 5.034M |
| September 30, 2019 | 21.33M |
| June 30, 2019 | 15.55M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 9.872M |
| Date | Value |
|---|---|
| September 30, 2018 | -0.019M |
| June 30, 2018 | 0.057M |
| March 31, 2018 | 0.294M |
| December 31, 2017 | 1.056M |
| September 30, 2017 | 0.453M |
| June 30, 2017 | 5.489M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.006M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.006M |
| December 31, 2015 | -26.01M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.013M |
| March 31, 2015 | 27.90M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 35.36M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 21.92M |
| March 31, 2013 | 0.115M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-27.36M
Minimum
Mar 2023
187.22M
Maximum
Sep 2020
24.57M
Average
0.336M
Median
Mar 2022
Cash from Financing (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | 0.377M |
| Bioventus Inc | -7.845M |
| Semler Scientific Inc | 0.111M |
| Liquidia Corp | -0.814M |
| Pfizer Inc | -2.459B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -30.14M |
| Cash from Investing (Quarterly) | -0.328M |
| Free Cash Flow | -71.16M |
| Free Cash Flow Per Share (Quarterly) | -1.130 |
| Free Cash Flow to Equity (Quarterly) | -30.47M |
| Free Cash Flow to Firm (Quarterly) | -30.47M |
| Free Cash Flow Yield | -14.50% |